$86.29▼ −0.35 · −0.4%from $86.64 the session before · Sep 30, 2026 close · end of day
Open
$86.21
High
$86.75
Low
$85.26
Day's range
$1.51.7% of the previous close
VWAP
$86.20close +0.11% from it
Volume, shares
3.47M0.86× the 20-session average
Traded, $
$299.5M
Trades
47.8K73 shares per trade
Previous close
$86.64−0.35 to the close
Market cap
$32.56Bat the close of Sep 30
Day range69% of the way up
$85.26$86.75
52-week range82% of the way up
$56.72 Apr 29$92.59 Aug 24
−6.8% from the high · +52% from the low
Options
No listed options on DXCM
Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
Revenue $1.31B, +13% on a year earlier; profit $249.1M, +39% in the Jun 2026 quarter, consolidated.
Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of DXCM on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue $
Revenue YoY
Profit $
Profit YoY
EPS $
Market on the day
Jun 2026filed Jul 30
$1.31B
▲ +13%
$249.1M
▲ +39%
0.64
▲ +12.0%S&P 500 +0.7% · +11.2 pp
Mar 2026filed Apr 30
$1.19B
▲ +15%
$199.5M
▲ +89%
0.51
▲ +3.0%S&P 500 +0.3% · +2.7 pp
Dec 2025filed Feb 12
$1.26B
▲ +13%
$267.3M
▲ +76%
0.67
—not reached
Sep 2025filed Oct 30
$1.21B
▲ +22%
$283.8M
▲ +110%
0.70
—not reached
Jun 2025filed Jul 30
$1.16B
▲ +15%
$179.8M
▲ +25%
0.45
▲ +12.0%S&P 500 +0.7% · +11.2 pp
Mar 2025filed Apr 30
$1.04B
▲ +12%
$105.4M
▼ −28%
0.27
▲ +3.0%S&P 500 +0.3% · +2.7 pp
Dec 2024filed Feb 18
$1.11B
▲ +7.6%
$151.7M
▼ −41%
0.37
—not reached
Sep 2024filed Oct 30
$994.2M
▲ +2.0%
$134.6M
▲ +12%
0.34
—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of DXCM on the consolidated basis, summed from the quarters filed
Year
Revenue $
Revenue YoY
Profit $
Profit YoY
EPS $
FY25to Dec 2025
$4.66B
▲ +16%
$836.3M
▲ +45%
2.09
FY24to Dec 2024
$4.03B
▲ +11%
$576.2M
▲ +6.4%
1.42
FY23to Dec 2023
$3.62B
▲ +24%
$541.5M
▲ +59%
1.30
FY22to Dec 2022
$2.91B
▲ +19%
$341.2M
▲ +57%
0.82
FY21to Dec 2021
$2.45B
▲ +27%
$216.9M
▼ −61%
0.53
Fundamentals
consolidated · filings to Jun 2026 · close $86.29 on Sep 30
DXCM trades at 34 times trailing earnings, 12 times book value, revenue +16% over twelve months, market cap $32.56B.
Valuation
Market cap
$32.56Bon Sep 30
Price to earnings
34consolidated · four quarters to Jun 2026
Trailing EPS
$2.52diluted · consolidated · four quarters to Jun 2026
Price to book
12consolidated · balance sheet to Jun 2026
Book value a share
$6.95consolidated · balance sheet to Jun 2026
Debt to equity
—
Return on equity
38%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
6.6market cap over revenue, four quarters to Jun 2026
Shares outstanding
377Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$4.97Bfour quarters to Jun 2026
Revenue growth, 12 months
▲ +16%against the twelve months before
Revenue 3-year CAGR
▲ +16%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$999.7Mfour quarters to Jun 2026
Profit growth, 12 months
▲ +75%against the twelve months before
Profit 3-year CAGR
▲ +41%trailing twelve months against the twelve months 3 years earlier · consolidated
PeersSurgical & Medical Instruments & Apparatus · the ten largest by market cap · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the industry Surgical & Medical Instruments & Apparatus with market cap, price to earnings and price to book
13F managers hold 200% of shares, BlackRock, Inc. the largest at 20%, VANGUARD CAPITAL MANAGEMENT LLC 13% and VANGUARD PORTFOLIO MANAGEMENT LLC 10%, as filed for the quarter to Jun 2026.
20.3%13.4%10.4%155.8%
BlackRock, Inc. 20.3%
VANGUARD CAPITAL MANAGEMENT LLC 13.4%
VANGUARD PORTFOLIO MANAGEMENT LLC 10.4%
Other 13F managers 155.8%
Held by 13F managers
200%of shares outstanding
Shares held
754M+5.6% on Mar 2026 among managers filing both
Managers holding
900891 a quarter earlier
Largest holder
20%BlackRock, Inc.
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of DXCM
Manager
Shares
Of outstanding
Value
Change on quarter
BlackRock, Inc.
76.5M
20%
$5.15B
−1.44M
VANGUARD CAPITAL MANAGEMENT LLC
50.4M
13%
$3.40B
+378K
VANGUARD PORTFOLIO MANAGEMENT LLC
39.3M
10%
$2.65B
+873K
STATE STREET CORP
36.8M
9.7%
$2.48B
+892K
Invesco Ltd.
30.6M
8.1%
$2.06B
+19.4M
BAILLIE GIFFORD & CO
29.6M
7.8%
$1.99B
−1.6M
GEODE CAPITAL MANAGEMENT, LLC
24.9M
6.6%
$1.67B
+160K
ALLIANCEBERNSTEIN L.P.
23.4M
6.2%
$1.47B
−2.46M
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
22.5M
6.0%
$1.52B
+3.03M
WELLINGTON MANAGEMENT GROUP LLP
17.1M
4.5%
$1.15B
−1.6M
Insider tradesSEC Forms 3, 4 and 5 · the latest 10
No open-market insider buying or selling in the last 90 days.
DXCM insider trades
Insider
Trade
Shares
Price
Held after
FOLETTA MARK GDirector
sold · Jun 15, 2026
199
$74.82
52,852
FOLETTA MARK GDirector
sold · Jun 15, 2026
3,801
$74.10
53,051
Brown Michael JonOfficer
sold · Jun 15, 2026
1,700
$75.55
106,353
Coleman JonOfficer
sold · Jun 4, 2026
4,911
$74.13
95,450
Coleman JonOfficer
sold · Jun 3, 2026
4,912
$73.00
100,361
GALA RENEE DDirector
granted · May 28, 2026
5,605
$0.00
12,486
Collins Richard AlexanderDirector
granted · May 28, 2026
5,605
$0.00
5,605
Ashley Euan A.Director
granted · May 28, 2026
5,565
$0.00
12,731
Driscoll RimmaDirector
granted · May 28, 2026
5,605
$0.00
17,319
Osterloh Albert Frederick IVDirector
granted · May 28, 2026
1,630
$0.00
8,691
Corporate actions
exchange records
No corporate action on record for DXCM yet.
Price history
131 sessions on record · to Sep 30 · end of day
DXCM is −4.3% over 20 sessions against the S&P 500's +0.1%, 6.8% below its 52-week high, realised volatility 23% annualised.
Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
Window
From $
DXCM %
S&P 500 %
Difference pp
120 sessionssince Apr 9
$65.68
▲ +31%
▲ +12%
+19
60 sessionssince Jul 7
$73.57
▲ +17%
▲ +2.0%
+15
20 sessionssince Sep 1
$90.14
▼ −4.3%
▲ +0.11%
−4.4
5 sessionssince Sep 23
$87.73
▼ −1.6%
▼ −0.67%
−0.97
1 sessionsince Sep 29
$86.64
▼ −0.40%
▼ −0.21%
−0.19
Averages of the closeclose against each average
5-session average
$86.74close −0.52% from it
20-session average
$86.96close −0.77% from it
50-session average
$85.78close +0.59% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$2.12.4% of the close
Average day's range, 20
$2.12.4% of the close
Volume against 20 sessions
0.86×3.47M vs 4.12M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
23%≈ ±1.5% a session · moved more than that on 7 of 20
Realised volatility, 60
40%≈ ±2.5% a session · moved more than that on 10 of 60
Beta to S&P 500, 60
0.39moved with S&P 500 on 30 of 60 sessions
Up and down sessionscloses above and below the previous close
Surgical & Medical Instruments & Apparatus · SEC standard industrial classification
SEC CIK
1093557
Sessions on record
131
Price source
End of day · delayed
Computed
1 Oct, 10:35 pm IST
OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.